Top Markets
Coin of the day
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Rang in Aktien #33424
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Aktienkurs
$0.17580153
Marktkapitalisierung
$7.59M
Veränderung (1 Tag)
-0.13%
Veränderung (1 Jahr)
-30.21%
Land
IN
Handel Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Kategorie

Dividendenrendite-Verlauf für Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)
Dividendenrendite (TTM) von Bharat Immunologicals & Biologicals Corporation Limited (Aktienkürzel: BIBCL) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Bharat Immunologicals & Biologicals Corporation Limited (BIBCL) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber